trans-4-Acetamidocyclohexaneacetic acid

Catalog No.: 
ACUIOM430
CAS No.: 
2901-44-2
Molecular Formula: 
C10H17NO3
Molecular Weight: 
199.25
trans-4-Acetamidocyclohexaneacetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$92.00In stockInquiry
1g98%$273.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-Acetamidocyclohexaneacetic acid
IUPAC Name2-((1r,4r)-4-acetamidocyclohexyl)acetic acid
Molecular FormulaC10H17NO3
Molecular Weight199.25
SMILESO=C(O)C[C@H]1CC[C@H](NC(C)=O)CC1
InChI KeyWFVBDJQHTIBXHZ-KYZUINATSA-N
SynonymNsc175383;2-((1r,4r)-4-acetaMidocyclohexyl)acetic acid;trans-4-Acetamidocyclohexaneacetic acid;Cyclohexaneacetic acid, 4-(acetylamino)-, trans-;Cariprazine intermediate 1;trans-2-(4-acetamidocyclohexyl)acetic acid;Cariprazine intermed
CAS No.2901-44-2
PubChem CID300538

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACUIOM430 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTBCR425 route compound structure diagram
    ACTBCR42576325-96-7In Stock
  4. Then
  5. ACUIOM430 route product structure diagram
    ACUIOM4302901-44-2In Stock
Inquiry

2. ACUIOM430 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUIOM430 route product structure diagram
    ACUIOM4302901-44-2In Stock
Inquiry

3. ACUIOM430 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUIOM430 route product structure diagram
    ACUIOM4302901-44-2In Stock
Inquiry

Comments (0)